HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and implications for drug design.

作者: Peng Zhan , Xuwang Chen , Dongyue Li , Zengjun Fang , Erik De Clercq

DOI: 10.1002/MED.20241

关键词: Structural diversityDrug discoveryDrugComputational biologyBroad spectrumVirologySimilarity (psychology)PharmacophoreDiarylpyrimidinesHuman immunodeficiency virus (HIV)Biology

摘要: Nonnucleoside reverse transcriptase inhibitors (NNRTIs) nowadays represent very potent and most promising anti-AIDS agents that specifically target the HIV-1 (RT). However, effectiveness of NNRTI drugs can be hampered by rapid emergence drug-resistant viruses severe side effects upon long-term use. Therefore, there is an urgent need to develop novel, highly NNRTIs with broad spectrum antiviral activity improved pharmacokinetic properties, more efficient strategies facilitate shorten drug discovery process would extremely beneficial. Fortunately, structural diversity provided a wide space for novel lead discovery, pharmacophore similarity gave valuable hints optimization. More importantly, continued efforts in development computational tools increased crystallographic information on RT/NNRTI complexes, structure-based approaches using combination traditional medicinal chemistry, biology, chemistry are being used increasingly design NNRTIs. First, this review covers two decades research various families based their chemical scaffolds, then describes We have attempted assemble comprehensive overview general optimization reported literature during last decade. The successful applications strategies, crystallography, designing highlighted. Future directions also outlined.

参考文章(340)
Yoel Kashman, Kirk R. Gustafson, Richard W. Fuller, John H. Cardellina, James B. McMahon, Michael J. Currens, Robert W. Buckheit, Stephen H. Hughes, Gordon M. Cragg, Michael R. Boyd, The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. Journal of Medicinal Chemistry. ,vol. 35, pp. 2735- 2743 ,(1992) , 10.1021/JM00093A004
R Silvestri, M Artico, B Bruno, S Massa, E Novellino, G Greco, ME Marongiu, A Pani, A De Montis, P La Colla, Synthesis and biological evaluation of 5H-indolo [3,2-b][1,5]benzothiazepine derivatives, designed as conformationally constrained analogues of the human immunodeficiency virus type 1 reverse transcriptase inhibitor L-737,126. Antiviral Chemistry & Chemotherapy. ,vol. 9, pp. 139- 148 ,(1998) , 10.1177/095632029800900205
Olga M Klibanov, Roberta L Kaczor, IDX-899, an aryl phosphinate-indole non-nucleoside reverse transcriptase inhibitor for the potential treatment of HIV infection. Current opinion in investigational drugs. ,vol. 11, pp. 237- 245 ,(2010)
Robert W Buckheit, Julie D Russell, Ze-Qi Xu, Michael Flavin, Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication. Antiviral Chemistry & Chemotherapy. ,vol. 11, pp. 321- 327 ,(2000) , 10.1177/095632020001100502
TK Venkatachalam, C Mao, FM Uckun, Stereochemistry as a Major Determinant of the Anti-HIV Activity of Chiral Naphthyl Thiourea Compounds: Antiviral Chemistry & Chemotherapy. ,vol. 12, pp. 213- 221 ,(2001) , 10.1177/095632020101200402
DL Taylor, PS Ahmed, P Chambers, AS Tyms, J Bedard, J Duchaine, G Falardeau, JF Lavallée, W Brown, RF Rando, T Bowlin, Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1. Antiviral Chemistry & Chemotherapy. ,vol. 10, pp. 79- 86 ,(1999) , 10.1177/095632029901000204
R Di Santo, R Costi, M Artico, S Massa, ME Marongiu, AG Loi, A De Montis, P La Colla, 1,2,5-Benzothiadiazepine and Pyrrolo[2,1-d]-[1,2,5]Benzothiadiazepine Derivatives with Specific Anti-Human Immunodeficiency Virus Type 1 Activity Antiviral Chemistry & Chemotherapy. ,vol. 9, pp. 127- 137 ,(1998) , 10.1177/095632029800900204
Yasuhisa Kurogi, Osman Guner, Pharmacophore modeling and three-dimensional database searching for drug design using catalyst. Current Medicinal Chemistry. ,vol. 8, pp. 1035- 1055 ,(2001) , 10.2174/0929867013372481
R. Pauwels, K. Andries, Z. Debyser, M. Kukla, D. Schols, J. Desmyter, E. De Clercq, P. A. J. Janssen, TIBO derivatives: a new class of highly potent and specific inhibitors of HIV-1 replication. Biochemical Society Transactions. ,vol. 20, pp. 509- 512 ,(1992) , 10.1042/BST0200509